Perioperative handling of antidiabetic drugs

• Published in: Chirurg Vol. 89; no. 2; pp. 103 - 107
• Main Authors: Wagner, J, Luber, V, Lock, J F, Dietz, U A, Lichthardt, S, Matthes, N, Krajinovic, K, Germer, C-T, Knop, S, Wiegering, A
• Format: Journal Article
• Language: German
• Published: Germany 01-02-2018
• Subjects: Chronic medication; Oral antidiabetic drugs; Hypoglycemia; Preoperative pause; Risk stratification
• ISSN: 1433-0385
• DOI: 10.1007/s00104-017-0527-8

Diabetes mellitus is the most frequent metabolic disorder in the western world with a prevalence of 3% in adults under 65 years of age and 14.3% in adults over 65 years of age. Due to the increasing age of our population, the number of patients taking oral antidiabetic drugs has increased. Thus, operating physicians must make a risk-adapted decision whether the medication can be continued perioperatively or if certain drugs must be paused, and if so, with what risks. Operative interventions can lead to a number of metabolic shifts, which change the normal glucose metabolism. Hyperglycemia in the perioperative period is a risk factor for postoperative sepsis, dysfunction of the endothelium, cerebral ischemia and poor wound healing. Due to perioperative fasting oral antidiabetic medication can lead to severe hypoglycemia if taken during this period. This leads to an increased morbidity and mortality in the perioperative period and extends the duration of stay in the intensive care unit (ICU) as well as the overall hospital stay. Oral antidiabetic medication should be paused on the day of the operation and restarted in line with the gradual postoperative return to solid food. Especially metformin, the most commonly used medication in the treatment of type 2 diabetes, should be paused perioperatively due to the severe side effect of lactate acidosis.